HUTCHMED (China) Ltd Files Routine 6-K Report
Ticker: HMDCF · Form: 6-K · Filed: Jun 3, 2024 · CIK: 1648257
Sentiment: neutral
Topics: sec-filing, 6-K, compliance
TL;DR
HUTCHMED filed a standard 6-K, no major news.
AI Summary
HUTCHMED (China) Limited filed a Form 6-K on June 3, 2024, reporting its status as a foreign private issuer. The company, previously known as Hutchison China MediTech Ltd, is incorporated in E9 and headquartered in Hong Kong. This filing is routine and does not contain specific financial or operational updates.
Why It Matters
This filing confirms HUTCHMED's ongoing compliance with SEC reporting requirements for foreign private issuers, providing transparency to investors.
Risk Assessment
Risk Level: low — This is a routine administrative filing and does not contain new material information that would typically impact risk.
Key Players & Entities
- HUTCHMED (China) Limited (company) — Registrant
- Hutchison China MediTech Ltd (company) — Former Company Name
- 001-37710 (company) — SEC File Number
- 20240603 (date) — Filing Date
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information which the issuer may be required to make public in its home country, or which it may publish or file with any stock exchange on which its securities are traded.
When was this Form 6-K filed?
This Form 6-K was filed on June 3, 2024.
What was HUTCHMED's former name?
HUTCHMED's former name was Hutchison China MediTech Ltd.
Where is HUTCHMED's principal executive office located?
HUTCHMED's principal executive office is located at 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong.
Does HUTCHMED file annual reports under Form 20-F or 40-F?
HUTCHMED indicates that it files annual reports under cover of Form 20-F.
Filing Stats: 167 words · 1 min read · ~1 pages · Grade level 13.2 · Accepted 2024-06-03 06:13:17
Filing Documents
- hcm-20240603x6k.htm (6-K) — 20KB
- hcm-20240603xex99d1.htm (EX-99.1) — 25KB
- hcm-20240603xex99d1001.gif (GRAPHIC) — 4KB
- 0001648257-24-000050.txt ( ) — 52KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of June 2024 Commission File Number: 001-37710 HUTCHMED (CHINA) LIMITED (Translation of registrant's name into English) 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F HUTCHMED (CHINA) LIMITED Form 6-K EXHIBIT INDEX Exhibit No. Description Exhibit 99.1 Press release relating to HUTCHMED highlights publication of Phase III FRUTIGA results in Nature Medicine 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. HUTCHMED (CHINA) LIMITED By: /s/ Johnny Cheng Name: Johnny Cheng Title: Chief Financial Officer Date: June 3, 2024 3